Skip to main content
. 2020 Jan 20;14:157–169. doi: 10.2147/OPTH.S199064

Figure 1.

Figure 1

Logarithmic scale representation of serum ME20-S levels in five groups of patients (Control, Choroidal Nevi, Untreated UM, 10-year disease-free (DFUM), hepatic metastatic UM). Significance level: ***p<0.001. Adapted from Bande MF, Santiago M, Mera P, et al. ME20-S as a potential biomarker for the evaluation of uveal melanoma. Invest Ophthalmol Vis Sci. 2015;56(12):7007–7011. Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.87